Globus Medical Statistics
Total Valuation
Globus Medical has a market cap or net worth of $10.96 billion. The enterprise value is $10.24 billion.
| Market Cap | 10.96B |
| Enterprise Value | 10.24B |
Important Dates
The next confirmed earnings date is Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Globus Medical has 134.26 million shares outstanding. The number of shares has decreased by -1.18% in one year.
| Current Share Class | 111.83M |
| Shares Outstanding | 134.26M |
| Shares Change (YoY) | -1.18% |
| Shares Change (QoQ) | -0.58% |
| Owned by Insiders (%) | 17.18% |
| Owned by Institutions (%) | 89.98% |
| Float | 110.92M |
Valuation Ratios
The trailing PE ratio is 20.89 and the forward PE ratio is 16.02. Globus Medical's PEG ratio is 1.22.
| PE Ratio | 20.89 |
| Forward PE | 16.02 |
| PS Ratio | 3.49 |
| Forward PS | 3.33 |
| PB Ratio | 2.30 |
| P/TBV Ratio | 4.16 |
| P/FCF Ratio | 14.51 |
| P/OCF Ratio | 12.04 |
| PEG Ratio | 1.22 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.13, with an EV/FCF ratio of 13.55.
| EV / Earnings | 19.12 |
| EV / Sales | 3.25 |
| EV / EBITDA | 10.13 |
| EV / EBIT | 14.01 |
| EV / FCF | 13.55 |
Financial Position
The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.62 |
| Quick Ratio | 2.78 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.15 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 11.81% and return on invested capital (ROIC) is 13.93%.
| Return on Equity (ROE) | 11.81% |
| Return on Assets (ROA) | 8.74% |
| Return on Invested Capital (ROIC) | 13.93% |
| Return on Capital Employed (ROCE) | 14.58% |
| Weighted Average Cost of Capital (WACC) | 9.43% |
| Revenue Per Employee | $524,156 |
| Profits Per Employee | $89,239 |
| Employee Count | 6,000 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.23 |
Taxes
In the past 12 months, Globus Medical has paid $124.69 million in taxes.
| Income Tax | 124.69M |
| Effective Tax Rate | 18.89% |
Stock Price Statistics
The stock price has increased by +30.18% in the last 52 weeks. The beta is 0.96, so Globus Medical's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +30.18% |
| 50-Day Moving Average | 78.24 |
| 200-Day Moving Average | 83.83 |
| Relative Strength Index (RSI) | 64.01 |
| Average Volume (20 Days) | 1,479,902 |
Short Selling Information
The latest short interest is 8.44 million, so 6.28% of the outstanding shares have been sold short.
| Short Interest | 8.44M |
| Short Previous Month | 6.62M |
| Short % of Shares Out | 6.28% |
| Short % of Float | 7.61% |
| Short Ratio (days to cover) | 5.50 |
Income Statement
In the last 12 months, Globus Medical had revenue of $3.14 billion and earned $535.43 million in profits. Earnings per share was $3.91.
| Revenue | 3.14B |
| Gross Profit | 2.17B |
| Operating Income | 730.32M |
| Pretax Income | 660.12M |
| Net Income | 535.43M |
| EBITDA | 1.01B |
| EBIT | 730.32M |
| Earnings Per Share (EPS) | $3.91 |
Balance Sheet
The company has $595.14 million in cash and $111.91 million in debt, with a net cash position of $728.59 million or $5.43 per share.
| Cash & Cash Equivalents | 595.14M |
| Total Debt | 111.91M |
| Net Cash | 728.59M |
| Net Cash Per Share | $5.43 |
| Equity (Book Value) | 4.77B |
| Book Value Per Share | 35.52 |
| Working Capital | 1.74B |
Cash Flow
In the last 12 months, operating cash flow was $910.39 million and capital expenditures -$154.80 million, giving a free cash flow of $755.59 million.
| Operating Cash Flow | 910.39M |
| Capital Expenditures | -154.80M |
| Depreciation & Amortization | 279.98M |
| Net Borrowing | n/a |
| Free Cash Flow | 755.59M |
| FCF Per Share | $5.63 |
Margins
Gross margin is 68.98%, with operating and profit margins of 23.22% and 17.03%.
| Gross Margin | 68.98% |
| Operating Margin | 23.22% |
| Pretax Margin | 20.99% |
| Profit Margin | 17.03% |
| EBITDA Margin | 32.12% |
| EBIT Margin | 23.22% |
| FCF Margin | 24.03% |
Dividends & Yields
Globus Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.18% |
| Shareholder Yield | 1.18% |
| Earnings Yield | 4.79% |
| FCF Yield | 6.89% |
Analyst Forecast
The average price target for Globus Medical is $100.92, which is 23.59% higher than the current price. The consensus rating is "Buy".
| Price Target | $100.92 |
| Price Target Difference | 23.59% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 6.89% |
| EPS Growth Forecast (3Y) | 13.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Globus Medical has an Altman Z-Score of 10.42 and a Piotroski F-Score of 7.
| Altman Z-Score | 10.42 |
| Piotroski F-Score | 7 |